|View printer-friendly version|
|February 14, 2002 4:09 p.m.|
|Teva Reports Record 2001 Q4 Sales of $ 567 Million; Over $ 2 Billion Sales for 2001; Earnings per ADR for Q4 (Before One-Time Charges) of $0.66|
Jerusalem, Israel, February 14, 2002 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) today reported net income, excluding one-time charges, for the fourth quarter ended December 31, 2001 of $89 million or $0.66 per fully diluted share, an increase of approximately 54%. Including a one-time restructuring expense of $16 million ($10 million after tax), recorded in the fourth quarter, net income amounted to $80 million or $0.59 per fully diluted share.